ASX:AJX

Stock Analysis Report

Alexium International Group

Executive Summary

Alexium International Group Limited develops and sells specialty chemicals and solutions in Australia and the United States.

Snowflake

Fundamentals

Worrying balance sheet with weak fundamentals.

Share Price & News

How has Alexium International Group's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

-7.7%

AJX

0.6%

AU Chemicals

0.4%

AU Market


1 Year Return

4.3%

AJX

16.1%

AU Chemicals

9.8%

AU Market

Return vs Industry: AJX underperformed the Australian Chemicals industry which returned 16.1% over the past year.

Return vs Market: AJX underperformed the Australian Market which returned 9.8% over the past year.


Shareholder returns

AJXIndustryMarket
7 Day-7.7%0.6%0.4%
30 Day-7.7%3.1%-1.3%
90 Day-27.3%7.6%-0.5%
1 Year4.3%4.3%19.2%16.1%16.1%9.8%
3 Year-81.0%-81.0%33.4%23.0%36.1%17.9%
5 Year-33.3%-33.3%54.3%31.6%49.4%15.7%

Price Volatility Vs. Market

How volatile is Alexium International Group's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Alexium International Group undervalued compared to its fair value and its price relative to the market?

74.14x

Price to Book (PB) ratio


Share Price vs. Fair Value

Below Fair Value: Insufficient data to calculate AJX's fair value to establish if it is undervalued.

Significantly Below Fair Value: Insufficient data to calculate AJX's fair value to establish if it is undervalued.


Price To Earnings Ratio

PE vs Industry: AJX is unprofitable, so we can't compare its PE Ratio to the Chemicals industry average.

PE vs Market: AJX is unprofitable, so we can't compare its PE Ratio to the Australian market.


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate AJX's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: AJX is overvalued based on its PB Ratio (74.1x) compared to the AU Chemicals industry average (5.1x).


Next Steps

Future Growth

How is Alexium International Group forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

30.0%

Forecasted Materials industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Alexium International Group has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Next Steps

Past Performance

How has Alexium International Group performed over the past 5 years?

3.7%

Historical annual earnings growth


Earnings and Revenue History


Past Earnings Growth Analysis

Earnings Trend: AJX is unprofitable, but has reduced losses over the past 5 years at a rate of 3.7% per year.

Accelerating Growth: Unable to compare AJX's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: AJX is unprofitable, making it difficult to compare its past year earnings growth to the Chemicals industry (1.8%).


Return on Equity

High ROE: AJX has a negative Return on Equity (-1811.9%), as it is currently unprofitable.


Return on Assets

ROA vs Industry: AJX is currently unprofitable, so its Return on Assets is negative.


Return on Capital Employed

ROCE Improving: AJX is currently unprofitable, so its Return on Capital Employed is negative.


Next Steps

Financial Health

How is Alexium International Group's financial position?


Financial Position Analysis

Short Term Liabilities: AJX's short term assets ($6.0M) exceeds its short term liabilities ($1.7M)

Long Term Liabilities: AJX's short term assets (6.0M) do not cover its long term liabilities (7.4M)


Debt to Equity History and Analysis

Debt Level: AJX's debt to equity ratio (1722.3%) is considered high

Reducing Debt: AJX's debt to equity ratio has increased from 42.9% to 1722.3% over the past 5 years.


Balance Sheet

Inventory Level: AJX has a high level of physical assets or inventory.

Debt Coverage by Assets: AJX's debt is not covered by short term assets (assets are 0.9x debt).


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: AJX has less than a year of cash runway based on its current free cash flow.

Forecast Cash Runway: AJX has less than a year of cash runway if free cash flow continues to grow at historical rates of 11.9% each year.


Next Steps

Dividend

What is Alexium International Group's current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

companyn/amarketbottom25%2.4%markettop25%5.6%industryaverage2.9%forecastin3Yearsn/a

Current dividend yield vs market & industry


Stability and Growth of Payments

Notable Dividend: Unable to evaluate AJX's dividend yield against the bottom 25% of dividend payers, as the company has not reported any payouts.

High Dividend: Unable to evaluate AJX's dividend yield against the top 25% of dividend payers, as the company has not reported any payouts.

Stable Dividend: Insufficient data to determine if AJX's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if AJX's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of AJX's dividend in 3 years as they are not forecast to pay a notable one for the Australian market.


Next Steps

Management

What is the CEO of Alexium International Group's salary, the management and board of directors tenure and is there insider trading?

1.8yrs

Average management tenure


CEO

Bob Brookins 0

1.4yrs

Tenure

US$480,131

Compensation

Dr. Robert Brookins, also known as Bob, Ph. D., M. A. E. B. A. B. Sc., has been the Chief Executive Officer and Managing Director at Alexium International Group Limited since May 31, 2018 and its Director  ...


CEO Compensation Analysis

Compensation vs. Market: Bob has recently become CEO, making it difficult to compare their total compensation against companies of similar size in the Australian market.

Compensation vs Earnings: Bob's compensation has increased whilst the company is unprofitable.


Management Age and Tenure

1.8yrs

Average Tenure

Experienced Management: AJX's management team is not considered experienced ( 1.8 years average tenure), which suggests a new team.


Board Age and Tenure

1.4yrs

Average Tenure

Experienced Board: AJX's board of directors are not considered experienced ( 1.4 years average tenure), which suggests a new board.


Insider Trading

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown


Management Team

  • Bob Brookins

    CEO, MD & Director

    • Tenure: 1.4yrs
    • Compensation: US$480.13k
  • Jason Lewis

    Chief Financial Officer

    • Tenure: 1.8yrs
    • Compensation: US$278.62k
  • Maja McGuire

    Company Secretary & General Counsel

    • Tenure: 1.7yrs
  • Mark Wise

    Vice President of Investor Relations & Corporate Communications

    • Tenure: 2.8yrs
  • Jessica Hutchison

    Vice President of Human Resources

    • Tenure: 2.8yrs
  • Scott Hunter

    Vice President of Sales

    • Tenure: 0yrs
  • Allen Reihman

    Chief Commercial Officer

    • Tenure: 1.8yrs
    • Compensation: US$273.71k

Board Members

  • Claire Poll (52yo)

    Independent Non-Executive Director

    • Tenure: 1.8yrs
    • Compensation: US$57.21k
  • Steve Cheney

    Deputy Chairman

    • Tenure: 1.5yrs
    • Compensation: US$71.25k
  • Bob Brookins

    CEO, MD & Director

    • Tenure: 1.4yrs
    • Compensation: US$480.13k
  • Rosheen Garnon

    Non-Executive Chairwoman

    • Tenure: 0.6yrs
    • Compensation: US$67.27k

Company Information

Alexium International Group Limited's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Alexium International Group Limited
  • Ticker: AJX
  • Exchange: ASX
  • Founded:
  • Industry: Diversified Chemicals
  • Sector: Materials
  • Market Cap: AU$41.698m
  • Shares outstanding: 347.49m
  • Website: https://www.alexiuminternational.com

Number of Employees


Location

  • Alexium International Group Limited
  • 125 St Georges Terrace
  • Level 11
  • Perth
  • Western Australia
  • 6000
  • Australia

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
AJXASX (Australian Securities Exchange)YesOrdinary SharesAUAUDMar 2010
E7TDB (Deutsche Boerse AG)YesOrdinary SharesDEEURMar 2010
AJXCHIA (Chi-X Australia)YesOrdinary SharesAUAUDMar 2010
AXXI.YOTCPK (Pink Sheets LLC)SPONSORED ADRUSUSDDec 2011

Biography

Alexium International Group Limited develops and sells specialty chemicals and solutions in Australia and the United States. The company offers flame retardant (FR) treatments, including Alexiflam FR for u ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/10/21 10:34
End of Day Share Price2019/10/21 00:00
Earnings2019/06/30
Annual Earnings2019/06/30


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.